KZR
Kezar Life Sciences Inc
0.175$
+6.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 92.5% | 92.5% | 93.5% | 93.2% | 93.2% | 95.3% | 95.0% | 96.1% | 95.9% | 96.7% | 98.8% | 99.4% | |
| 10.7% | 10.6% | 16.0% | 16.6% | 15.7% | 21.2% | 28.9% | 29.5% | 31.5% | 39.8% | 93.8% | 97.4% | |
| 89.8% | 87.5% | 91.0% | 90.3% | 91.3% | 90.4% | 91.4% | 91.3% | 92.4% | 92.3% | 93.8% | 97.4% | |
| – | 2.8% | 1.0% | 1.5% | 0.9% | 0.7% | 0.3% | 1.8% | 1.8% | 2.0% | 2.5% | – | |
| – | 1.8% | – | – | – | – | 0.4% | – | – | – | – | – | |
| 5.1% | – | – | – | – | – | – | – | – | – | – | – | |
| 11.8% | 13.4% | 15.2% | 15.1% | 16.2% | 18.3% | 19.2% | 17.7% | 15.9% | 15.1% | 8.6% | 4.1% | |
| 5.2% | 6.7% | 8.0% | 8.1% | 9.7% | 12.5% | 14.1% | 13.5% | 13.2% | 13.7% | 8.6% | 4.1% | |
| 1.1% | 1.2% | 1.4% | 2.2% | 3.3% | 4.5% | 6.0% | 7.1% | 11.8% | 12.1% | 3.0% | 2.0% | |
| 0.9% | 1.3% | 3.7% | 2.5% | 1.3% | 2.1% | 2.5% | 1.6% | 1.1% | 0.9% | 0.7% | 0.4% | |
| 3.8% | 4.0% | 4.6% | 4.4% | 4.2% | 3.9% | 3.5% | 3.1% | 2.4% | 1.4% | – | – | |
| 88.2% | 86.6% | 84.8% | 84.9% | 83.8% | 81.7% | 80.8% | 82.3% | 84.1% | 84.9% | 91.4% | 95.9% | |
| -112.2% | -127.7% | -158.5% | -187.0% | -219.0% | -252.5% | -300.3% | -360.1% | -425.9% | -487.1% | -640.0% | -729.8% | |
| 27.5% | 29.2% | 32.9% | 36.6% | 40.5% | 44.5% | 5.0% | 5.8% | 6.7% | 7.5% | 9.5% | 10.8% |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.